Amarin Corp Plc (AMRN)

[ziploc_1]

DMC....QUOTE..."In this prospective, multicenter, randomized, open-label, blinded end-point study, patients with stable coronary artery disease and a low EPA/AA ratio (<0.4) were randomized to EPA (1800 of icosapent ethyl administered daily)"

This study demonstrates that the dosage of EPA is important...In the RI study, the daily dosage of EPA was over twice as much as in this study....i.e. 4000 mgms. of EPA daily in R.I. as compared with 1800 in this study.

This is further evidence that OTC omega 3 products, containing lesser amounts of EPA than Vascepa(together with unhelpful DNA) are not as effective as pure Vascepa.